Evidence map›Paper›PMID 34162890›Full record

ArticleNature communications2021

Author Correction: Deep learning boosts sensitivity of mass spectrometry-based immunopeptidomics.

Mathias Wilhelm, Daniel P Zolg, Michael Graber, Siegfried Gessulat, Tobias Schmidt, Karsten Schnatbaum, Celina Schwencke-Westphal, Philipp Seifert, Niklas de Andrade Krätzig, Johannes Zerweck and 14 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

Mathias Wilhelm *Computational Mass Spectrometry, Technical University of Munich (TUM), Freising, Germany. mathias.wilhelm@tum.de.ORCID http://orcid.org/0000-0002-9224-3258
Daniel P Zolg *Chair of Proteomics and Bioanalytics, Technical University of Munich (TUM), Freising, Germany.
Michael GraberChair of Proteomics and Bioanalytics, Technical University of Munich (TUM), Freising, Germany.
Siegfried GessulatChair of Proteomics and Bioanalytics, Technical University of Munich (TUM), Freising, Germany.ORCID http://orcid.org/0000-0001-5530-0674
Tobias SchmidtChair of Proteomics and Bioanalytics, Technical University of Munich (TUM), Freising, Germany.ORCID http://orcid.org/0000-0002-1883-6514
Karsten SchnatbaumJPT Peptide Technologies GmbH, Berlin, Germany.
Celina Schwencke-WestphalKlinik und Poliklinik für Innere Medizin III, Klinikum rechts der Isar, School of Medicine, Technical University of Munich (TUM), Munich, Germany.ORCID http://orcid.org/0000-0002-5105-4290
Philipp SeifertKlinik und Poliklinik für Innere Medizin III, Klinikum rechts der Isar, School of Medicine, Technical University of Munich (TUM), Munich, Germany.
Niklas de Andrade KrätzigCenter for Translational Cancer Research (TranslaTUM), TUM School of Medicine, Technical University of Munich (TUM), Munich, Germany.
Johannes ZerweckJPT Peptide Technologies GmbH, Berlin, Germany.
Tobias KnauteJPT Peptide Technologies GmbH, Berlin, Germany.
Eva BräunleinKlinik und Poliklinik für Innere Medizin III, Klinikum rechts der Isar, School of Medicine, Technical University of Munich (TUM), Munich, Germany.
Patroklos SamarasChair of Proteomics and Bioanalytics, Technical University of Munich (TUM), Freising, Germany.ORCID http://orcid.org/0000-0001-6042-1585
Ludwig LautenbacherChair of Proteomics and Bioanalytics, Technical University of Munich (TUM), Freising, Germany.ORCID http://orcid.org/0000-0002-1540-5911
Susan KlaegerBroad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-0074-5163
Holger WenschuhJPT Peptide Technologies GmbH, Berlin, Germany.
Roland RadCenter for Translational Cancer Research (TranslaTUM), TUM School of Medicine, Technical University of Munich (TUM), Munich, Germany.ORCID http://orcid.org/0000-0002-6849-9659
Bernard DelangheThermo Fisher Scientific, Bremen, Germany.
Andreas HuhmerThermo Fisher Scientific, San Jose, CA, USA.
Steven A CarrBroad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-7203-4299
Karl R ClauserBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Angela M KrackhardtKlinik und Poliklinik für Innere Medizin III, Klinikum rechts der Isar, School of Medicine, Technical University of Munich (TUM), Munich, Germany.ORCID http://orcid.org/0000-0002-4752-0543
Ulf ReimerJPT Peptide Technologies GmbH, Berlin, Germany.
Bernhard KusterChair of Proteomics and Bioanalytics, Technical University of Munich (TUM), Freising, Germany. kuster@tum.de.ORCID http://orcid.org/0000-0002-9094-1677

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34162890
PMCPMC8222294

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.